Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.18%62.03B | 1.31%14.66B | 2.73%16.59B | 14.57%15.97B | 2.71%14.81B | 26.20%58.97B | 22.18%14.47B | 24.81%16.15B | 25.06%13.94B | 33.44%14.42B |
Cost of revenue | 4.86%53.84B | -0.40%12.73B | 1.57%14.32B | 13.51%13.86B | 5.51%12.93B | 28.08%51.35B | 21.76%12.78B | 27.26%14.1B | 29.35%12.21B | 35.04%12.26B |
Gross profit | 7.33%8.18B | 14.26%1.93B | 10.80%2.26B | 22.07%2.11B | -13.12%1.88B | 14.85%7.62B | 25.44%1.69B | 10.13%2.04B | 1.28%1.73B | 25.06%2.16B |
Operating expense | 3.51%6.53B | 2.61%1.61B | -2.51%1.65B | 8.78%1.67B | 5.80%1.59B | 6.13%6.31B | 5.58%1.57B | 6.02%1.69B | 6.51%1.54B | 6.45%1.51B |
Staff costs | 4.87%2.3B | 4.91%659.03M | 1.48%536.3M | 6.87%560.49M | 6.28%539.58M | 3.17%2.19B | 5.06%628.2M | 2.18%528.47M | 2.17%524.47M | 2.96%507.7M |
Selling and administrative expenses | 1.03%2.64B | 3.35%1.66B | -6.01%345.14M | 2.55%326.04M | -3.97%310.45M | 8.43%2.61B | 7.06%1.6B | 10.91%367.2M | 9.11%317.94M | 12.01%323.27M |
-Selling and marketing expense | 3.16%711.3M | ---- | ---- | ---- | ---- | 5.85%689.52M | ---- | ---- | ---- | ---- |
-General and administrative expense | 0.27%1.93B | 3.50%945.15M | -6.01%345.14M | 2.55%326.04M | -3.97%310.45M | 9.39%1.92B | 7.99%913.19M | 10.91%367.2M | 9.11%317.94M | 12.01%323.27M |
Depreciation and amortization | 15.24%198.07M | ---- | ---- | ---- | ---- | -5.71%171.88M | ---- | ---- | ---- | ---- |
-Depreciation | 15.24%198.07M | ---- | ---- | ---- | ---- | -5.71%171.88M | ---- | ---- | ---- | ---- |
Other operating expenses | 4.61%1.4B | -8.39%-900.45M | -3.54%765M | 13.07%788.14M | 10.11%743.24M | 8.49%1.33B | -5.39%-830.73M | 6.51%793.12M | 8.80%697.04M | 6.63%675.02M |
Operating profit | 25.60%1.65B | 169.70%317.7M | 74.33%616.88M | 131.46%432.65M | -56.37%287.45M | 89.38%1.32B | 183.08%117.8M | 35.12%353.86M | -27.89%186.93M | 108.27%658.84M |
Net non-operating interest income (expenses) | -23.28%-86.44M | -11.86%-21.65M | -13.57%-21.62M | -38.47%-23.67M | -33.29%-19.51M | -22.03%-70.12M | -38.83%-19.36M | -30.64%-19.03M | -16.78%-17.09M | -2.26%-14.64M |
Non-operating interest income | -5.15%8.77M | -17.05%2.22M | 63.20%3.02M | -28.84%1.61M | -21.79%1.92M | 2.35%9.24M | 12.49%2.67M | -40.96%1.85M | 31.22%2.26M | 36.59%2.46M |
Non-operating interest expense | 19.97%95.21M | 8.35%23.87M | 17.96%24.63M | 30.61%25.27M | 25.36%21.43M | 19.35%79.36M | 34.99%22.03M | 17.98%20.88M | 18.30%19.35M | 6.09%17.1M |
Net investment income | 830.30%155.86M | 131.91%45.17M | 142.63%6.64M | 3.86%64.54M | -46.32%39.52M | -119.62%-21.34M | -320.45%-141.52M | -215.01%-15.57M | 882.02%62.14M | 197.72%73.61M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 1,598.55%104.12M | 100K | 0 | 379.53%6.13M | 0 | 486.75%6.13M | ||||
Income from associates and other participating interests | 588.37%17.22M | 4,611.72%10.78M | 249.63%2.24M | 474.32%4.42M | 63.93%-220K | 58.24%-3.53M | 87.05%-239K | 28.88%-1.5M | 53.98%-1.18M | 68.38%-610K |
Special income (charges) | -6,800.52%-251.25M | -2,366.57%-89.51M | -1,336,491.67%-160.39M | 34K | -1.38M | 28.11%-3.64M | -19.97%-3.63M | 83.10%-12K | 0 | 0 |
Less:Other special charges | 2,352.98%89.31M | 2,328.11%88.12M | ---148K | ---34K | --1.38M | -25.77%3.64M | 19.97%3.63M | ---- | ---- | ---- |
Less:Write off | --161.94M | --1.4M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Other non-operating income (expenses) | 66.24%163.34M | 117.40%113.66M | -36.39%11.42M | 44.06%25.18M | 24.03%13.09M | 77.24%98.25M | 274.51%52.28M | 10.50%17.95M | 33.00%17.48M | -12.77%10.55M |
Income before tax | 27.49%1.69B | 5,635.01%305.68M | 33.16%455.16M | 144.56%607.18M | -56.17%318.94M | 68.19%1.32B | 106.46%5.33M | 25.06%341.82M | -5.10%248.27M | 117.74%727.76M |
Income tax | 28.77%590.11M | 147.42%75.11M | 69.35%186.81M | 72.76%203.47M | -37.58%124.72M | 88.00%458.25M | 248.90%30.36M | 16.66%110.3M | 60.71%117.78M | 107.47%199.82M |
Net income | 26.81%1.1B | 1,021.22%230.56M | 15.91%268.35M | 209.37%403.71M | -63.21%194.22M | 59.30%864.92M | 59.68%-25.03M | 29.50%231.52M | -30.71%130.5M | 121.90%527.94M |
Net income continuous operations | 26.81%1.1B | 1,021.22%230.56M | 15.91%268.36M | 209.36%403.71M | -63.21%194.22M | 59.30%864.92M | 59.68%-25.03M | 29.50%231.51M | -30.71%130.5M | 121.90%527.94M |
Noncontrolling interests | -34.99%47.28M | 218.38%23.23M | 74.04%5.92M | 63.40%12.74M | -93.36%5.39M | 604.99%72.73M | 38.89%-19.63M | -78.15%3.4M | 143.82%7.8M | 242.89%81.16M |
Net income attributable to the company | 32.49%1.05B | 3,937.31%207.33M | 15.05%262.44M | 218.64%390.97M | -57.73%188.83M | 48.73%792.19M | 81.97%-5.4M | 39.76%228.11M | -33.73%122.7M | 108.54%446.78M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 32.49%1.05B | 3,937.31%207.33M | 15.05%262.44M | 218.64%390.97M | -57.73%188.83M | 48.73%792.19M | 81.97%-5.4M | 39.76%228.11M | -33.73%122.7M | 108.54%446.78M |
Gross dividend payment | ||||||||||
Basic earnings per share | 32.14%135.62 | 3,870.42%26.77 | 14.69%33.88 | 218.74%50.52 | -57.81%24.45 | 48.52%102.63 | 81.75%-0.71 | 39.54%29.54 | -34.01%15.85 | 108.45%57.95 |
Diluted earnings per share | 32.14%135.62 | 3,870.42%26.77 | 14.69%33.88 | 218.74%50.52 | -57.81%24.45 | 48.52%102.63 | 81.75%-0.71 | 39.54%29.54 | -34.01%15.85 | 108.45%57.95 |
Dividend per share | 25.00%30 | 25.00%30 | 0 | 0 | 0 | 71.43%24 | 71.43%24 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |